Regarding patients with systemic viral infections (VIH, VHC, VHB), they have been excluded in the clinical studies to ensure the protection of lab workers from risks related to exposure of biological agents at work. On the other hand, the impact of viral infections, typical in KT recipients, on the IMMUNOBIOGRAM® remains to be checked in clinical studies.